超声增强剂市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00039130
  • Category : Medical Device
  • Status : Data Released
  • No. of Pages : 150
Buy Now

超声增强剂 市场预测是根据各种二级和一级研究来源的发现得出的。 Insight Partners估计,2023年市场价值为7.5661亿美元,预计到2031年将达到25.1152亿美元;预计 2023 年至 2031 年复合年增长率为 16.2%。

超声增强剂,也称为超声波在超声扫描期间注射造影剂(UCA)以增强器官图像的分辨率。这些药剂由小于红细胞的充气微泡悬浮液组成,当它们流经血管中的微循环时反射超声波信号。注射后几分钟内,它们会通过尿液或排便排出体外。这些药剂不含任何染料,被认为是安全的,因为它们不会造成已知的肾毒性风险。

驱动因素超声增强剂市场增长

超声成像目前是评估肿瘤疾病严重程度的第一步,心血管疾病,为通过进一步研究进行准确评估和诊断铺平道路。由于系统的便携性、低成本、安全性和诊断能力,它被广泛用于身体部位的实时成像以检测异常。此外,使用造影剂显着提高了超声检测疾病早期阶段的敏感性和特异性,从而为该领域的细胞和分子研究开辟了新的可能性。癌症、肾脏疾病和肝脏疾病等慢性疾病的患病率激增,推动了对早期诊断以更好地管理的需求。他们的诊断需要先进的成像方式来对诊断患者进行早期检测和健康监测。超声增强剂可以增强肿瘤、病变和异常组织生长的可视化。根据 2023 年 9 月发表在 radiopaedia.org 上的一篇文章,超声成像中使用的造影剂 Sonazoid 可以增强肝脏在血管后阶段的对比度,有助于检测肝脏肿瘤,特别是那些没有库普弗细胞转移的肿瘤。 Sonazoid 还有助于区分肝硬化肝脏中早期肝细胞癌的再生结节和发育不良结节。因此,UCA在诊断成像中的日益普及推动了超声增强剂的市场规模。

根据国际超声造影协会 (ICUS) 2021 年 10 月发表的一篇文章,57 项原始研究仅针对儿科患者,其中包括 4,518 名儿童,截至 2021 年 8 月,他们接受了 4,906 次静脉造影增强超声检查。此外,为评估临床安全性而制定的综合方案证明了 UCA 在静脉内、膀胱内使用时具有非常有利的安全性,以及通过其他腔内手术。

报告细分和范围:

“全球超声增强剂市场分析”到 2031 年”是一项专门且深入的研究,重点关注全球市场动态,以帮助确定关键驱动因素、未来趋势和利润丰厚的机会,从而有助于确定主要收入来源。该报告旨在提供市场概况,并按类型、应用程序和最终用户进行详细的市场细分。 超声增强剂市场报告的地理范围包括北美(美国、加拿大和墨西哥)、欧洲(西班牙、英国、德国、法国、意大利和欧洲其他地区)、亚太地区(韩国、中国、印度、日本、澳大利亚和亚太地区其他地区)、中东和美国非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美和非洲中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)。

细分分析:

超声增强剂市场按类型划分,分为第一代和 >第二代。第二代细分市场将在 2023 年占据更大的市场份额。预计 2023 年至 2031 年复合年增长率将更高。

市场按应用细分为:腹部成像、心血管成像、泌尿道成像等。 2023 年,腹部成像领域占据了最大的超声增强剂市场份额。心血管成像领域预计 2023 年至 2031 年复合年增长率最高。

根据最终用户,市场分为医院、诊断和成像中心以及其他医院细分市场在 2023 年占据最大的市场份额。此外,诊断和影像中心细分市场预计将实现最高的复合年增长率2023年至2031年

区域展望:

2023 年,北美拥有最大的超声增强剂市场份额。就份额而言,美国在该地区占据主导地位,其次是加拿大。美国市场的增长归因于主要参与者的存在等因素,包括 Lantheus Holdings Inc. 和 GE Healthcare。这些公司越来越注重合资企业和研究合作。例如,GE Healthcare 致力于通过推出创新产品并与竞争对手建立战略合作伙伴关系来扩大其产品组合。此外,有利的报销政策导致超声手术数量激增,支持了美国超声增强剂市场的增长。

< strong>行业发展和未来机遇:

根据公司新闻稿,全球主要参与者采取的一些举措;超声增强剂市场如下:

    2024 年 3 月,Samsung Medison 和 Bracco Imaging 签署了一项2 月 28 日至 3 月 3 日在奥地利维也纳举行的 2024 年欧洲放射学大会 (ECR) 上签署了开发诊断超声设备和造影剂新领域的谅解备忘录 (MoU)。两家公司正在考虑合作开发用于诊断的高频和超分辨率成像协议。此次合作还将包括营销活动、医疗保健提供者的合作。教育,以及利用药剂探索超声靶向对比增强药物输送技术。2023 年 4 月,GE HealthCare 推出了 Pixxoscan(Gadobutrol)。它是一种用于非离子磁共振成像的大环钆基造影剂 (GBCA)。该产品已添加到该公司的 MRI 造影剂产品组合中,其中包括 Claiscan(大环钆特酸)和 Rapiscan(用于应激心脏 MR,以帮助诊断冠状动脉疾病)

竞争格局和主要公司:

Lantheus Holdings Inc.;通用电气医疗保健; Solstice Pharmaceuticals BV;富士胶片视觉索尼公司;博莱科诊断公司;拜耳公司;和 Vesselon 是超声增强剂市场报告中介绍的知名公司之一。这些公司专注于新技术、现有产品的进步和地域扩张,以满足全球不断增长的消费者需求。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is ultrasound-enhancing agent?

Ultrasound-enhancing agents, also known as ultrasound contrast agents (UCA), are injected to enhance the resolution of images of the organs during an ultrasound scan. These agents consist of suspensions of gas-filled microbubbles smaller than red blood cells and reflect ultrasound signals as they flow through the microcirculation in the blood vessels. They are expelled from the body via urine or bowel movements, within minutes after injection. These agents do not contain any dyes and are considered safe as they pose no known risk of nephrotoxicity.

What factors drive the ultrasound-enhancing agents market?

Key factors driving the ultrasound-enhancing agents informatics growth are the increasing investments in the R&D of new drug molecules by pharmaceutical companies and the growing adoption of computational and information tools for ultrasound-enhancing agents and development.

What was the estimated ultrasound-enhancing agents market size in 2023?

The ultrasound-enhancing agents informatics was valued at US$ 756.61 million in 2023.

What are the growth estimates for the ultrasound-enhancing agents market till 2031?

The ultrasound-enhancing agents market is expected to be valued at US$ 2,511.52 million in 2031.

Which type segment dominates the ultrasound-enhancing agents market?

The ultrasound-enhancing agents market is bifurcated into the first generation and second generation. The second generation segment held a larger market share in 2023. It is projected to register a higher CAGR from 2023 to 2031.

Who are the major players in the ultrasound-enhancing agents market?

The ultrasound-enhancing agents market majorly consists of the players, including Lantheus Holdings Inc.; GE Healthcare; Solstice Pharmaceuticals B.V.; FUJIFILM VisualSonics, Inc.; Bracco Diagnostics Inc.; Bayer AG; and Vesselon.

The List of Companies - Ultrasound-Enhancing Agents Market

  1. Lantheus Holdings Inc.
  2. GE Healthcare
  3. Solstice Pharmaceuticals BV
  4. FUJIFILM VisualSonics, Inc.
  5. Bracco Diagnostics Inc.
  6. Bayer AG
  7. Vesselon

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports